Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur zu Teil I (Kapitel 1–5)
Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE (1991) A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 151: 933–938
Attia J, Ray JG, Cook DJ, Douketis J, Ginsberg JS, Geerts WH (2001) Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med 161: 1268–1279
Baglin TP, White K, Charles A (1997) Fatal pulmonary embolism in hospitalized medical patients. J Clin Pathol 50: 609–610
Bergqvist D, Jendteg S, Johansen L, Persson U, Odegaard K (1997) Cost of long-term complications of deep venous thrombosis of the lower extremities: an analysis of a defined patient population in Sweden. Ann Intern Med 126: 454–457
Beyth RJ, Cohen AM, Landefeld CS (1995) Long-term outcomes of deep-vein thrombosis. Arch Intern Med 155: 1031–1037
Bona RD, Sivjee KY, Hickey AD, Wallace SB, Wajcs SB (1995) The efficacy and safety of oral anticoagulation in patients with cancer. Thromb Haemost 74: 1055–1058
Bosson JL, Labarere J, Sevestre MA, Belmin J, Beyssier L, Elias A, Franco A, Le Roux P (2003) Deep vein thrombosis in elderly patients hospitalized in subacute care facilities. Arch Intern Med 163: 2613–2618
Boulay F, Berthier F, Schoukroun G, Raybaut C, Gendreike Y, Blaive B (2001) Seasonal variations in hospital admission for deep vein thrombosis and pulmonary embolism: analysis of discharge data. BMJ 323: 601–602
Caprini JA, Botteman MF, Stephens JM, Nadipelli V, Ewing MM, Brandt S, Pashos CL, Cohen AT (2003) Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. Value Health 6: 59–74
Deitcher SR (2003) Cancer-related deep venous thrombosis: clinical importance, treatment challenges, and management strategies. Thromb Haemost 29: 247–258
Geerts WH, Heit JA, Clagett CP, Pineo GF, Colwell CW, Anderson FA, Wheeler HB (2001) Prevention of venous thromboembolism. Chest 119: 132S–175S
Geerts WH, Code KI, Jay RM, Chen E, Szalai JP (1994) A prospective study of venous thromboembolism after major trauma. N Engl J Med 331: 1601–1606
Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM (1999a) Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med 130: 800–809
Gould MK, Dembitzer AD, Sanders GD, Garber AM (1999b) Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. Ann Intern Med 130: 789–799
Gregory PC, Kuhlemeier KV (2003) Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke. Am J Phys Med Rehabil 82: 364–369
Haas S (2003) Venous thromboembolism in medical patients-the scope of the problem. Thromb Haemost 29[Suppl]: 17–21
Hansson PO, Welin L, Tibblin G, Eriksson H (1997) Deep vein thrombosis and pulmonary embolism in the general population. ‘The Study of Men Born in 1913’. Arch Intern Med 157: 1665–1670
Hansson PO, Sorbo J, Eriksson H (2000) Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 160: 769–774
Heit JA, Mohr DN, Silverstein ME et al. (2000) Predictors of recurrence after deep vein thrombosis and pulmonary embolism. A population-based cohort study. Arch Intern Med 160: 761–768
Hutten BA, Prins MH, Gent M et al. (2000) Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol 8: 3078–3083
reference>Kahn SR, Hirsch A, Shrier I (2002) Effect of post-thrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med 162: 1144–1148
Kahn SR, Ginsberg JS (2004) Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med 164: 17–26
Kearon C (2003) Natural history of venous thromboembolism. Circulation 107: I-22–I-30
Kelly J, Rudd T, Lewis RR, Hunt BJ (2002) Mortality from pulmonary embolism after acute stroke: can we do better? Age and Ageing 31: 159–161
Kniffin WD Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr (1994) The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 154: 861–866
Langhorne P, Stott DJ, Robertson J, MacDonald J, Jones L, McAlpine C, Dick F, Taylor GS, Murray G (2000) Medical complications after stroke: a multicenter study. Stroke 31: 1223–1229
Leclerc JR, Gent M, Hirsh J et al. (1998) The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study in patients who underwent hip or knee arthroplasty. Arch Intern Med 158: 873–878
Lee AYY, Levine MN (2003) Venous thromboembolism and cancer: risks and outcomes. Circulation 107: I-17–I-21
Lensing AWA, Prandoni P, Prins MH, Büller HR (1999) Deep-vein thrombosis. Lancet 353: 479–485
Levitan N, Dowlati A, Remick SC et al. (1999) Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine 78: 285–291
McBride D, Brüggenjürgen B, Roll S, Willich SN (2004) Cost and outcomes in thrombosis prophylaxis after hip and knee replacement: Results of the TOCA study. Biom J 46[Suppl]: 36
Nicolaides AN, Breddin HK, Fareed J, Goldhaber S, Haas S, Hull R, Kalodiki E, Myers K, Samama M, Sasahara A; Cardiovascular Disease Educational and Research Trust and the International Union of Angiology (2001) Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol 20: 1–37
Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T (1992) A prospective study of the incidence of deep-vein thrombosis within a defined urban population.: J Intern Med 232: 155–160
Pambianco G, Orchard T, Landau P (1995) Deep vein thrombosis: prevention in stroke patients during rehabilitation. Arch Phys Med Rehabil 76: 324–330
Prandoni P, Lensing AW, Cogo A et al. (1996) The long term clinical course of acute deep venous thrombosis. Ann Intern Med 125: 1–7
Prandoni P, Lensing AW, Piccioli A et al. (2002) Recurrent venous thromboembolism and bleeding complications during anti-coagulant treatment in patients with cancer and venous thrombosis. Blood 100: 3484–3488
Rogers FB (2001) Venous thromboembolism in trauma patients: a review. Surgery 130: 1–12
Roth EJ, Lovell L, Harvey RL, Heinemann AW, Semik P, Diaz S (2001) Incidence and risk factors for medical complications during stroke rehabilitation. Stroke 32: 523–529
Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ 3rd (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158: 585–93
Simmons AV, Sheppard MA, Cox AF (1973) Deep venous thrombosis after myocardial infarction. Lancet 35: 623–625
Sorenson HT, Mellemkjaer L, Steffenson FH, Olsen JH, Nielsen GL (1998) The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 338: 1169–1173
Stein PD, Kayali F, Olson RE (2004) Analysis of occurrence of venous thromboembolic disease in the four seasons. Am J Cardiol 93: 511–513
Szucs TD, Schramm W (1999) The cost-effectiveness of low-molecular-weight heparin vs unfractionated heparin in general and orthopaedic surgery: an analysis for the German healthcare system. Pharmacol Res 40: 83–89
Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR (2002) Cardiovascular risk factors and venous thromboembolism incidence. Arch Intern Med 162: 1182–1189
Versio M, Agnelli G (2003) Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 21: 3665–3675
White RH (2003) The epidemiology of venous thromboembolism. Circulation 107: I-4–I-8
White RH, Romano PS, Zhou H, Rodrigo J, Bargar W (1998a) Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 158: 1525–1531
White RH, Zhou H, Romano PS (1998b) Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 128: 737–740
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Müller-Nordhorn, J., Willich, S.N. (2005). Sozialmedizinische und sozioökonomische Bedeutung. In: Haas, S. (eds) Prävention von Thrombosen und Embolien in der Inneren Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27118-X_5
Download citation
DOI: https://doi.org/10.1007/3-540-27118-X_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-22563-8
Online ISBN: 978-3-540-27118-5
eBook Packages: Medicine (German Language)